Asbestos toxicity: an immunologic perspective.
Asbestos has long been associated with a number of life threatening pulmonary diseases, including asbestosis and mesothelioma. While the lung is the primary target organ for asbestos toxicity, a number of clinical and experimental studies over the past 30 years have shown that the immune system may also be altered by exposure to asbestos at occupationally relevant concentrations. Whereas early clinical studies generally focused on systemic observations of immune alteration, more recent studies have assessed the immunological changes occurring in the lung, the primary target organ of asbestos. This review will focus on the investigations that examine the influence of asbestos on systemic and local immunity, as well as the role that the immune system may play in asbestos-related disease.
Rosenthal
G J
GJ
RxKinetix, Inc., Louisville, CO 80027, USA. rosenthal@rxkinetix.com
Simeonova
P
P
Corsini
E
E
D000917:Antibody Formation; D001194:Asbestos / Q000009:adverse effects* / Q000737:chemistry; D001195:Asbestosis / Q000276:immunology*; D001402:B-Lymphocytes / Q000187:drug effects / Q000276:immunology; D006801:Humans; D007107:Immune System / Q000187:drug effects*; D007694:Killer Cells, Natural / Q000187:drug effects / Q000276:immunology; D008264:Macrophages / Q000187:drug effects / Q000276:immunology; D016273:Occupational Exposure / Q000009:adverse effects; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology
D001194:Asbestos